Global Portal Hypertension Management Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Portal Hypertension Management Market?
The market size for managing portal hypertension has seen a remarkable growth in the recent past. Projected to rise from $3.07 billion in 2024 to $3.27 billion in 2025, it boasts a compound annual growth rate (CAGR) of 6.5%. Former growth in this market can be linked to a number of factors. These include a rise in liver disease cases, an increase in the elderly population, initiatives surrounding awareness and screening, the financial impact of liver diseases, approval for new medication and treatment options, and enhancements in diagnostic techniques.
Expectations are high for a strong expansion in the portal hypertension management market in the coming years. The market size is predicted to reach $4.15 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be linked to factors such as increased investments in healthcare infrastructure, wider reach of health insurance coverage, favourable regulations and faster authorization processes. Ongoing research and development activities aimed at understanding the pathophysiology of portal hypertension, coupled with remote monitoring technologies for uninterrupted patient management, also contribute to this growth. The forecast period will witness key trends like adoption of telemedicine on a wider scale, ongoing improvements in medical technology including the growth of bio-engineered liver tissue, advancements in personalized medicine, development of targeted therapies personalized for each patient, and enhanced diagnostic techniques such as non-invasive imaging technology like elastography.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16515&type=smp
What Core Drivers Are Expected To Influence The Portal Hypertension Management Market?
The growing number of cases related to liver diseases such as hepatitis is foreseen to accelerate the expansion of the portal hypertension management market. Liver disease is an umbrella term covering a variety of conditions that disrupt the structure or functionality of the liver, frequently resulting in symptoms like jaundice, fatigue, and abdominal pain. These ailments can often be traced back to viral infections, excessive alcohol intake, or metabolic issues. Instances of liver diseases are commonly attributed to alcohol usage, viral hepatitis afflictions, fat deposition in the liver due to obesity, and metabolic complications. The objective of portal hypertension management in those suffering from liver disease is to lessen pressure in the portal vein system. This intervention helps mitigate the adverse effects of variceal bleeding, ascites, and hepatic encephalopathy, thus improving patient prognosis. As an illustration, Cancer Australia, a government cancer agency based in Australia, reported around 2,905 new liver cancer diagnoses in Australia in September 2022, divided into 2,113 males and 792 females. Moreover, the probability of contracting liver cancer by age 85 is anticipated to be 1 in 103 (or 0.97%) in 2022, 1 in 70 (or 1.4%) for males, and 1 in 195 (or 0.51%) for females. Consequently, the escalating occurrence of liver diseases is fueling the growth of the portal hypertension management market.
What Are The Main Segment Classifications In The Portal Hypertension Management Market?
The portal hypertension managementmarket covered in this report is segmented –
1) By Treatment Type: Medications; Non-Surgical Procedures; Surgery
2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS); Other Procedure Types
3) By End-User: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Medications: Beta-Blockers; Vasodilators; Diuretics; Antibiotics; Other Medications
2) By Non-Surgical Procedures: Endoscopic Variceal Ligation (EVL); Endoscopic Sclerotherapy; Transjugular Intrahepatic Portosystemic Shunt (TIPS); Balloon Occlusion
3) By Surgery: Liver Transplantation; Portosystemic Shunt Surgery; Surgical Decompression Of Portal Vein; Other Surgical Procedures
How Are Industry Trends Steering The Expansion Of The Portal Hypertension Management Market?
Major players in the portal hypertension management market are transitioning towards utilizing advanced minimally invasive devices in order to improve treatment results and minimize procedural risks. Meant for procedures that cause minimal disturbance to surrounding tissues, these minimally invasive devices are typically applied via small incisions or natural body openings. For example, in November 2023, Medtronic Plc, a medical device production company in the US, secured approval from the U.S. Food and Drug Administration (FDA) for the use of Symplicity Spyral renal denervation (RDN), a minimally invasive device designed to treat hypertension. The procedure utilizes radiofrequency energy to address nerves near the kidneys, effectively soothing them, to manage hypertension.
Which Companies Are Contributing Significantly To The Portal Hypertension Management Market Growth?
Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Portal Hypertension Management Market Expansion?
North America was the largest region in the portal hypertension management market in 2024. The regions covered in the portal hypertension management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16515&type=smp
Browse Through More Reports Similar to the Global Portal Hypertension Management Market 2025, By The Business Research Company
Pulmonary Arterial Hypertension Global Market Report 2025
Ocular Hypertension Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report
Medical Waste Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-waste-management-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
